Progesterone Receptor Positive (PR+) Breast Cancer: Characteristics, Treatment and Prognosis
PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment ...
ER+ and PR+ Breast Cancer: Key Statistics and Molecular Insights
ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...
The Jambar2 天
Precision Medicine in Breast Cancer: A New Hope for Personalized Treatments
By Kolade Adeyemo / Jambar Contributor Breast cancer is one of the most prevalent cancers worldwide, affecting millions of ...
来自MSN16 天
What To Know About HR+/HER2- Breast Cancer
HR+/HER2- breast cancer—or hormone receptor-positive, HER2-negative breast cancer—is the most common subtype of breast cancer. It makes up about 70% of all breast cancer cases. HR+/HER2- breast cancer ...
Column: Mifepristone is effective, medically sound and needed
It would be short-sided, erroneous and dangerous to think ill of mifepristone, which has several important applications,, M.D ...
Science Daily1 个月
Postpartum depression discovery opens door to blood test, earlier treatment
New postpartum depression findings could lead to a blood test to identify women at risk and possibly even to a preventive treatment. New postpartum depression research from the University of ...
The Virginian-Pilot6 天
Column: Mifepristone is effective, medically sound and needed
At low doses it blocks the naturally occurring hormone progesterone from binding to its receptor in the body. This is one of the mechanisms by which it has been used in abortion care, as it blocks ...